Afimkibart — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12-31 in 3mo
ESTIMATED |
READOUT
Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Di
Phase 2 · Crohns Disease |
Hoffmann-La Roche | Afimkibart |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|